Compare · LFST vs TOI
LFST vs TOI
Side-by-side comparison of LifeStance Health Group Inc. (LFST) and The Oncology Institute Inc. (TOI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LFST and TOI operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- LFST is the larger of the two at $4.73B, about 9.2x TOI ($512.9M).
- Over the past year, LFST is up 133.0% and TOI is up 34.0% - LFST leads by 98.9 points.
- LFST has hit the wire 4 times in the past 4 weeks while TOI has been quiet.
- LFST has more recent analyst coverage (17 ratings vs 8 for TOI).
- Company
- LifeStance Health Group Inc.
- The Oncology Institute Inc.
- Price
- $11.73-5.10%
- $5.12+5.13%
- Market cap
- $4.73B
- $512.9M
- 1M return
- -6.87%
- -3.12%
- 1Y return
- +132.97%
- +34.03%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2020
- News (4w)
- 4
- 0
- Recent ratings
- 17
- 8
LifeStance Health Group Inc.
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. The company offers patients care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was incorporated in 2021 and is based in Scottsdale, Arizona.
The Oncology Institute Inc.
The Oncology Institute, Inc. provides cancer awareness, prevention, diagnosis, treatment, and education service. The company offers chemotherapy education, comprehensive lab testing, pain management, financial counseling, end of life counseling, dietary counseling, in-house infusion center, in-house support groups, in-house pharmacy, nutraceuticals, clinical trials, and educational seminars. It also operates the hope, health, and healing center to offer patients alternative and holistic treatments in addition to chemotherapy. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
Latest LFST
- SEC Form 8-K filed by LifeStance Health Group Inc.
- LifeStance to Host Third Quarter 2026 Earnings Conference Call on November 5, 2026
- Nearly Half of Americans Say Fear of an Unwanted Viral Moment Keeps Them from Being Themselves in Public, LifeStance Survey Finds
- Chief Executive Officer Bourdon David gifted 300,000 shares and received a gift of 300,000 shares, decreasing direct ownership by 24% to 948,247 units (SEC Form 4)
- Large owner Tpg Gp A, Llc sold $226,255,274 worth of shares (18,409,705 units at $12.29) (SEC Form 4)
- SEC Form 8-K filed by LifeStance Health Group Inc.
- SEC Form 424B7 filed by LifeStance Health Group Inc.
- LifeStance Health Group Announces Pricing of Secondary Public Offering
- SEC Form 424B7 filed by LifeStance Health Group Inc.
- LifeStance Health Group Announces Launch of Secondary Public Offering
Latest TOI
- The Oncology Institute Inc. filed SEC Form 8-K: Leadership Update
- Director Hively Brad sold $1,946,310 worth of shares (298,853 units at $6.51), decreasing direct ownership by 42% to 411,976 units (SEC Form 4)
- The Oncology Institute Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Large owner Chernett Jorey bought $78,480 worth of shares (12,000 units at $6.54), increasing direct ownership by 0.11% to 10,660,858 units (SEC Form 4)
- SEC Form 10-Q filed by The Oncology Institute Inc.
- The Oncology Institute Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- The Oncology Institute Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits
- The Oncology Institute Rebrands as Starling Oncology
- Director Kaushal Mohit was granted 33,133 shares, increasing direct ownership by 19% to 205,716 units (SEC Form 4)
- Director Mcgeorge Anne was granted 41,165 shares, increasing direct ownership by 14% to 332,535 units (SEC Form 4)